Skip to main content

Advertisement

SpringerLink
Log in

“Modern Endovascular Therapy”

  • Surgical Symposium Contribution
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Introduction

The past 25 years have been witness to a revolution in how vascular care is delivered. The majority of arterial and venous interventions have converted from open surgery to minimally invasive percutaneous endovascular procedures.

Methods

This surgical innovations symposium article reviews current endovascular therapy in multiple vascular beds with a primary focus on carotid artery occlusive disease, aortic pathologies, and lower extremity arterial occlusive disease. Mesenteric arterial occlusive disease and lower extremity venous endovascular therapies are also briefly discussed. Indications for intervention, treatment examples and outcomes analysis are presented. While not reviewed in this article, endovascular therapy has also become first line in the treatment of coronary artery disease, chronic mesenteric arterial occlusive disease, superficial venous reflux, central vein occlusion, and acute venous thrombus intervention when indicated.

Conclusion

Endovascular therapies are used in all vascular beds to treat the full spectrum of vascular pathologies. Aneurysm disease, atherosclerotic arterial occlusive disease, acute arterial and venous thrombosis, ongoing hemorrhage, and venous reflux are among the issues which can be addressed by endovascular means. The minimally invasive nature of endovascular treatments in what is largely a very co-morbid patient cohort is an attractive method of avoiding major procedural related morbidity and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. North American Symptomatic Carotid Endarterectomy Trial Collaborators, Barnett HJM, Taylor DW, et al. (1991) Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 325(7): 445‐453

  2. Moore WS, Young B, Baker WH, Robertson JT, Toole JF, Vescera CL, Howard VJ (1996) Surgical results: a justification of the surgeon selection process for the ACAS trial. ACAS Investig J Vasc Surg 23(2):323–328

    CAS  Google Scholar 

  3. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ et al (2004) Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351:1493–1501

    CAS  PubMed  Google Scholar 

  4. Brott TG, Hobson RW 2nd, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF; CREST Investigators (2010) Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 363(1): 11–23

  5. Sabat J, Bock D, Hsu CH, Tan TW, Weinkauf C, Trouard T, Perez-Carrillo GG, Zhou W (2020) Risk factors associated with microembolization after carotid intervention. J Vasc Surg 71(5):1572–1578

    PubMed  Google Scholar 

  6. Brott TG, Howard G, Roubin GS, Meschia JF, Mackey A, Brooks W, Moore WS, Hill MD, Mantese VA, Clark WM, Timaran CH, Heck D, Leimgruber PP, Sheffet AJ, Howard VJ, Chaturvedi S, Lal BK1, Voeks JH, Hobson RW 2nd; CREST Investigators (2016) Long-Term results of stenting versus endarterectomy for carotid-artery stenosis. N Engl J Med 374(11): 1021–1031

  7. Schermerhorn ML, Liang P, Eldrup-Jorgensen J, Cronenwett JL, Nolan BW, Kashyap VS et al (2019) Association of transcarotid artery revascularization vs transfemoral carotid artery stenting with stroke or death among patients with carotid artery stenosis. JAMA 322:2313–2322

    PubMed  PubMed Central  Google Scholar 

  8. Howard VJ, Meschia JF, Lal BK, Turan TN, Roubin GS, Brown RD Jr, Voeks JH, Barrett KM, Demaerschalk BM, Huston J, Lazar RM, Moore WS, Wadley VG, Chaturvedi S, Moy CS, Chimowitz M, Howard G, Brott TG (2017) Carotid revascularization and medical management for asymptomatic carotid stenosis: protocol of the CREST-clinical trials CREST- study investigators. Int J Stroke 12(7):770–778

    PubMed  PubMed Central  Google Scholar 

  9. Parodi JC, Palmaz JC, Barone HD (1991) Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg 5:491–499

    CAS  PubMed  Google Scholar 

  10. Buck DB, Karthaus EG, Soden PA, Ultee KHJ, Van Herwaarden JA, Moll FL et al (2015) Percutaneous versus femoral cutdown access for endovascular aneurysm repair. J Vasc Surg 62:16–21

    PubMed  PubMed Central  Google Scholar 

  11. Columbo JA, Ramkumar N, Martinez-Camblor P, Kang R, Suckow BD, NO’Malley AJ, Sedrakyan A, Goodney PP (2020) Five-year reintervention after endovascular abdominal aortic aneurysm repair in the vascular quality initiative. J Vasc Surg 71(3):799–805

    PubMed  Google Scholar 

  12. Faries PL, Cadot H, Agarwal G, Craig Kent K, Hollier LH, Marin ML (2003) Management of endoleak after endovascular aneurysm repair: Cuffs, coils, and conversion. J Vasc Surg 37:1155–61

    PubMed  Google Scholar 

  13. Rayt HS, Sandford RM, Salem M, Bown MJ, London NJ, Sayers RD (2009) Conservative management of type 2 endoleaks is not associated with increased risk of aneurysm rupture. J Vasc Surg 50(6):1529–1530

    Google Scholar 

  14. Stavropoulos SW, Park J, Fairman R, Carpenter J (2009) Type 2 endoleak embolization comparison: translumbar embolization versus modified transarterial embolization. J Vasc Interv Radiol 20:1299–1302

    PubMed  Google Scholar 

  15. Thomas WR, Karkhanis S, Hopkins J, Duddy M (2020) Translumbar embolization of type ii endoleaks: 12 years of experience at a regional vascular centre. Vasc Endovascular Surg 13:1538574420918972

    Google Scholar 

  16. Scali ST, Vlada A, Chang CK, Beck AW (2013) Transcaval embolization as an alternative technique for the treatment of type II endoleak after endovascular aortic aneurysm repair. J Vasc Surg 57(3):869–874

    PubMed  PubMed Central  Google Scholar 

  17. Schermerhorn ML, Buck DB, O’Malley AJ, Curran T, McCallum JC, Darling J et al (2015) Long-term outcomes of abdominal aortic aneurysm in the medicare population. N Engl J Med 373:328–338

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Patel R, Sweeting MJ, Powell JT, Greenhalgh RM (2016) Endovascular versus open repair of abdominal aortic aneurysm in 15-years’ follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial. Lancet 388:2366–2374

    PubMed  Google Scholar 

  19. Lederle FA, Kyriakides TC, Stroupe KT, Freischlag JA, Padberg FT Jr, Matsumura JS, Huo Z, Johnson GR (2019) OVER veterans affairs cooperative study group. “open versus endovascualr repair of abdominal aortic aneurysm.” N Engl J Med 380(22):2126–2135

    PubMed  Google Scholar 

  20. van Schaik TG, Yeung KK, Verhagen HJ, de Bruin JL, van Sambeek MRHM, Balm R, Zeebregts CJ, van Herwaarden JA, Blankensteijn JD (2017) DREAM trial participants “Long-term survival and secondary procedures after open or endovascular repair of abdominal aortic aneurysms.” J Vasc Surg 66(5):1379–1389

    PubMed  Google Scholar 

  21. Dua A, Kuy S, Lee CJ, Upchurch GR, Desai SS (2014) Epidemiology of aortic aneurysm repair in the United States from 2000 to 2010. J Vasc Surg 59:1512–1517

    PubMed  Google Scholar 

  22. Dake MD (2001) Endovascular stent-graft management of thoracic aortic diseases. Eur J Radiol 39:42–49

    CAS  PubMed  Google Scholar 

  23. Fattori R, Montgomery D, Lovato L, Kische S, Di Eusanio M, Ince H, Eagle KA, Isselbacher EM, Nienaber CA (2013) JACC Cardiovasc Interv 6(8):876–82

    PubMed  Google Scholar 

  24. Abel D, Morales JP (2011) Food and Drug Administration commentary on the SVS masterfile for acute complicated type B aortic dissections and transections. J Vasc Surg 53:1079–1081

    PubMed  Google Scholar 

  25. Nienaber CA, Kische S, Zeller T, Rehders TC, Schneider H, Lorenzen B et al (2006) Provisional extension to induce complete attachment after stent-graft placement in type B aortic dissection: the PETTICOAT concept. J Endovasc Ther 13:738–746

    PubMed  Google Scholar 

  26. Konstantinou N, Debus ES, Vermeulen C, Wipper S, Diener H, Larena-Avellaneda A et al (2019) Cervical debranching in the endovascular era: a single-center experience. Eur J Vasc Endovasc Surg 58:34–40

    PubMed  Google Scholar 

  27. Arnaoutakis DJ, Scali ST, Beck AW, Kubilis P, Huber TS, Martin AJ, Laquian L, Back M, Giles KA, Fatima J, Beaver TM, Upchurch GR Jr (2020) Comparative outcomes of open, hybrid, and fenestrated branched endovascular repair of extent II and III thoracoabdominal aortic aneurysms. J Vasc Surg 71:1503–14

    PubMed  Google Scholar 

  28. Tsilimparis N, Law Y, Rohlffs F, Spanos K, Debus ES, Kölbel T (2020) Fenestrated endovascular repair for diseases involving the aortic arch. J Vasc Surg 71:1464–71

    PubMed  Google Scholar 

  29. Motta F, Vallabhaneni R, Kalbaugh CA, Alyateem G, Marston WA, Farber MA (2019) Comparison of commercially available versus customized branched-fenestrated devices in the treatment of complex aortic aneurysms. J Vasc Surg 69(3):645–650

    PubMed  Google Scholar 

  30. Pearce BJ, Scali ST, Beck AW (2017) The role of surgeon modified fenestrated stent grafts in the treatment of aneurysms involving the branched visceral aorta. J Cardiovasc Surg (Torino) 58:861–869

    Google Scholar 

  31. Della Schiava N, Arsicot M, Boudjelit T, Feugier P, Lermusiaux P, Millon A (2016) “Conformability of GORE excluder iliac branch endoprosthesis and COOK zenith bifurcated iliac side branched iliac stent grafts.” Ann Vasc Surg 36:139–144

    PubMed  Google Scholar 

  32. Zhu J, Dai X, Noiniyom P, Luo Y, Fan H, Feng Z et al (2019) Fenestrated thoracic endovascular aortic repair using physician-modified stent grafts (PMSGs) in Zone 0 and zone 1 for aortic arch diseases. Cardiovasc Intervent Radiol 42:19–27

    PubMed  Google Scholar 

  33. Schwierz E, Kolvenbach RR, Yoshida R, Yoshida W, Alpaslan A, Karmeli R (2014) Experience with the sandwich technique in endovascular thoracoabdominal aortic aneurysm repair. J Vasc Surg 59:1562–1569

    PubMed  Google Scholar 

  34. GT Taneva, FJ Criado, G Torsello, F Veith, ST Scali, P Kubilis, and KP Donas, on behalf of the PERICLES collaborators (2020) “Results of chimney endovascular aneurysm repair as used in the PERICLES Registry to treat patients with suprarenal aortic pathologies”. J Vasc Surg 71: 1521–1527

  35. Abu Dabrh AM, Steffen MW, Asi N, Undavalli C, Wang Z, Elamin MB et al (2016) Bypass surgery versus endovascular interventions in severe or critical limb ischemia. J Vasc Surg 63:244–253

    PubMed  Google Scholar 

  36. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45(Suppl S):S5-67

    PubMed  Google Scholar 

  37. Siracuse JJ, Menard MT, Eslami MH, Kalish JA, Robinson WP, Eberhardt RT et al (2016) Comparison of open and endovascular treatment of patients with critical limb ischemia in the vascular quality initiative. J Vasc Surg 63(958–965):e1

    Google Scholar 

  38. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I et al (2010) Bypass versus angioplasty in Severe Ischaemia of the Leg (BASIL) trial: analysis of amputation free and overall survival by treatment received. J Vasc Surg 51(Suppl):18S-31S

    PubMed  Google Scholar 

  39. Michael S. Conte, MD, Andrew W. Bradbury, MD, Philippe Kolh, MD (Co-Editor), John V. White, MD (Steering Committee), Florian Dick, MD (Steering Committee), Robert Fitridge, MBBS (Steering Committee), Joseph L. Mills, MD (Steering Committee), Jean-Baptiste Ricco, MD (Steering Committee), Kalkunte R. Suresh, MD (Steering Committee), M. Hassan Murad, MD, MPH, and the GVG Writing Group (2019) “Global vascular guidelines on the management of chronic limb-threatening ischemia” J Vasc Surg 69: 3S-125S

  40. DeRubertis BG, Pierce M, Chaer RA, Rhee SJ, Benjeloun R, Ryer EJ et al (2007) Lesion severity and treatment complexity are associated with outcome after percutaneous infra-inguinal intervention. J Vasc Surg 46:709–716

    PubMed  Google Scholar 

  41. Chang RW, Goodney PP, Baek JH, Nolan BW, Rzucidlo EM, Powell RJ (2008) Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease. J Vasc Surg 48:362–367

    PubMed  Google Scholar 

  42. Schneider PA, Caps MT, Ogawa DY, Hayman ES (2001) Intraoperative superficial femoral artery balloon angioplasty and popliteal to distal bypass graft: an option for combined open and endovascular treatment of diabetic gangrene. J Vasc Surg 33:955–962

    CAS  PubMed  Google Scholar 

  43. Gandini R, Del Giudice C, Simonetti G (2014) Pedal and plantar loop angioplasty: technique and results. J Cardiovasc Surg (Torino) 55:665–670

    CAS  Google Scholar 

  44. Shammas NW, Lam R, Mustapha J, Ellichman J, Aggarwala G, Rivera E et al (2012) Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the CALCIUM 360 randomized pilot trial. J Endovasc Ther 19:480–8

    PubMed  Google Scholar 

  45. Zeller T, Baumgartner I, Scheinert D, Brodmann M, Bosiers M, Micari A et al (2014) Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. J Am Coll Cardiol 64:1568–76

    PubMed  Google Scholar 

  46. Setacci C, Chisci E, de Donato G, Setacci F, Iacoponi F, Galzerano G (2009) Subintimal angioplasty with the aid of a re-entry device for TASC C and D lesions of the SFA. Eur J Vasc Endovasc Surg 38:76–87

    CAS  PubMed  Google Scholar 

  47. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB et al (2011) Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv 4:495–504

    CAS  PubMed  Google Scholar 

  48. Bekken J, Jongsma H, Ayez N, Hoogewerf CJ, Van Weel V, Fioole B (2015) Angioplasty versus stenting for iliac artery lesions. Cochrane Database Syst Rev (5): CD007561

  49. Almasri J, Adusumalli J, Asi N, Lakis S, Alsawas M, Prokop LJ et al (2018) A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia. J Vasc Surg 68:624–633

    PubMed  Google Scholar 

  50. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W et al (2006) Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354:1879–1888

    CAS  PubMed  Google Scholar 

  51. Saxon RR, Dake MD, Volgelzang RL, Katzen BT, Becker GJ (2008) Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 19:823–832

    PubMed  Google Scholar 

  52. Dosluoglu HH, Cherr GS, Lall P, Harris LM, Dryjski ML (2008) Stenting vs above knee polytetrafluoroethylene bypass for transatlantic inter-society consensus-II C and D superficial femoral artery disease. J Vasc Surg 48:1166–1174

    PubMed  Google Scholar 

  53. Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, MenaHurtado C, Metzger DC et al (2015) Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med 373:145–153

    CAS  PubMed  Google Scholar 

  54. Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Karnabatidis D (2018) Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J American Heart Assoc 7(24):e011245

    Google Scholar 

  55. Geraghty PJ, Mewissen WM, Jaff MR, Ansel GM (2013) Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. J Vasc Surg 58:386–95

    PubMed  Google Scholar 

  56. Liistro F, Porto I, Angioli P, Grotti S, Ricci L, Ducci K et al (2013) Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation 128(615–21):393

    Google Scholar 

  57. Todd KE, Ahanchi SS, Maurer CA, Kim JH, Chipman CR, Panneton JM (2013) Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia. J Vasc Surg 58:941–948

    PubMed  Google Scholar 

  58. Ambler GK, Radwan R, Hayes PD, Twine CP (2014) Atherectomy for peripheral arterial disease. Cochrane Database Syst Rev 3:CD006680

    Google Scholar 

  59. Baumann F, Bloesch S, Engelberger RP, Makaloski V, Fink H, Do DD et al (2013) Clinically-driven need for secondary interventions after endovascular revascularization of tibial arteries in patients with critical limb ischemia. J Endovasc Ther 20:707–713

    PubMed  Google Scholar 

  60. Lo RC, Darling J, Bensley RP, Giles KA, Dahlberg SE, Hamdan AD et al (2013) Outcomes following infrapopliteal angioplasty for critical limb ischemia. J Vasc Surg 57:1455–1464

    PubMed  PubMed Central  Google Scholar 

  61. Saqib NU, Domenick N, Cho JS, Marone L, Leers S, Makaroun MS et al (2013) Predictors and outcomes of restenosis following tibial artery endovascular interventions for critical limb ischemia. J Vasc Surg 57:692–699

    PubMed  Google Scholar 

  62. Bosiers M, Kallakuri S, Deloose K, Verbist J, Peeters P (2008) Infragenicular angioplasty and stenting in the management of critical limb ischaemia: one year outcome following the use of the MULTI-LINK VISION stent. EuroIntervention 3:470–474

    PubMed  Google Scholar 

  63. Giles KA, Pomposelli FB, Hamdan AD, Blattman SB, Panossian H, Schermerhorn ML (2008) Infrapopliteal angioplasty for critical limb ischemia: relation of transatlantic intersociety consensus class to outcome in 176 limbs. J Vasc Surg 48:128–136

    PubMed  Google Scholar 

  64. Baril DT, Rhee RY, Kim J, Makaroun MS, Chaer RA, Marone LK (2009) Duplex criteria for determination of in-stent stenosis after angioplasty and stenting of the superficial femoral artery. J Vasc Surg 49:133–139

    PubMed  Google Scholar 

  65. Kwolek C, Shuma F (2014) “Acute ischemia” rutherford’s vascular surgery, 8th edn. Elsevier Publishing, Amsterdam, pp 2528–2543

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Loyola University Medical Center, 2160 S. First Ave, EMS Building 110, Room 3213, Maywood, IL, 60153, USA

    Matthew Blecha & Vivian Gahtan

  2. Edward Hines Jr VA Hospital, Hines, IL, USA

    Vivian Gahtan

Authors
  1. Matthew Blecha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vivian Gahtan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew Blecha.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is a contribution to the Surgical Innovation Symposium

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Blecha, M., Gahtan, V. “Modern Endovascular Therapy”. World J Surg 45, 3493–3502 (2021). https://doi.org/10.1007/s00268-020-05875-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-020-05875-7

Search

Navigation